Investing
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.
It will be used to accelerate collaborations with pharmaceutical firms.
It will use its latest funds for its global expansion.
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.
The new funds will be used to support the rollout of its hypertension DTx app.
The startup connects new mental health providers with supervisors to complete their licensure requirements. The new funding brings its total raise to $16.3 million.
It is now preparing for a Series A fundraising round in the next six months.
Medication management-focused Arine raised $29 million, Epic-based virtual care platform KeyCare scooped up $24 million, and care coordination software company CareHarmony raised $15 million.
The virtual reality startup said the investment brings its total raise to more than $30 million.
The startup's tool records and transcribes conversations between providers and patients, and then organizes relevant information about health conditions, symptoms and next steps.